Description
Enzalutamide, sold under the brand name Bdenza, is a nonsteroidal antiandrogen (NSAA) which is used for the treatment of metastatic, castration-resistant prostate cancer (CRPC).
| Strength | Not specified |
| Pack Size | Not specified |
| Brand | Not specified |
| Packaging Type | Not specified |
| Composition | Not specified |
| Form | Not specified |
| Shelf Life | Not specified |
| Usages | Not specified |
| Country of Origin | Not specified |
Reviews
There are no reviews yet.